Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad183 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Feixue Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, Anus Neoplasms, Carcinoma in Situ. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Background
We sought to summarize human papillomavirus (HPV) vaccine efficacy/effectiveness (VE) against anal HPV infection and anal intraepithelial neoplasia (AIN).
Methods
We performed literature review and meta-analysis to estimate VE, stratified by age and analytic population (per-protocol efficacy [PPE] or intention-to-treat [ITT] population in clinical trials, or all participants in real-world studies).
Results
We identified 6 clinical trials and 8 real-world studies. In participants vaccinated at age ≤26 years (mainly human immunodeficiency virus [HIV]–negative individuals), significant VE against incident/prevalent anal HPV infection was reported in clinical trials, with a higher estimate in PPE (2 studies with 2390 participants; VE, 84% [95% confidence interval (CI), 77%–90%]; I2 = 0%) than ITT (2 studies with 4885 participants; 55%, 39%–67%; I2 = 46%) populations or in real-world studies (4 studies with 2375 participants; 77%, 40%–91%; I2 = 81%). HPV vaccination at age ≤26 years was associated with significant VE in preventing persistent anal HPV infection and AIN. No significant VE against anal HPV infection or AIN was found in persons vaccinated at age >26 years (mainly people living with HIV).
Conclusions
There is strong evidence for high VE against anal HPV infection and AIN in HIV-negative individuals vaccinated at age ≤26 years. However, the lower impact in ITT than in PPE populations and the lack of significant effect in people living with HIV aged >26 years indicates that vaccines have the higher impact in populations with less sexual exposure to anal HPV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
- Department of Infectious Diseases, Public Health Service Amsterdam, Amsterdam, the Netherlands.
- Department of Epidemiology and Data Science, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
- Gastroenterology Department, Fernando Pessoa Teaching Hospital, São Cosme, Portugal.
- Precancerous Lesions and Early Cancer Management Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
ORCID-Profile: Feixue Wei, Andreia Albuquerque, Gary M Clifford
Förderung
- World Health Organization
Zitieren
APA
Wei, F., Alberts, C. J., Albuquerque, A., & Clifford, G. M. (2023). Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad183
Vancouver
Wei F, Alberts CJ, Albuquerque A, Clifford GM. Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad183
BibTeX
@article{Wei2023,
author = {Wei, Feixue and Alberts, Catharina J and Albuquerque, Andreia and Clifford, Gary M},
title = {Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad183}
}
EUVIMED